About CSL
CSL focuses on the areas of Rare & Serious Diseases and Vaccines. Today, we compete on the global stage as one of the largest and fastest growing protein-based biotechnology businesses, and a leading provider of in-licensed vaccines.
CSL Behring is a global provider of plasma-derived & recombinant products. We have created one of the largest and most efficient plasma collection networks in the world and our team of over 1,100 R&D experts is dedicated to developing and delivering new therapies to solve unmet medical needs and save lives. Our products are used around the world to treat immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders.
Our Commitment
CSL Behring is passionate about safety, quality and the customers we serve. Our extensive research and development and range of support services demonstrate our ongoing commitment to those who count on our products. Our five core company values underscore our commitment to providing the best possible therapies and services:
- Patient Focus
- Innovation
- Integrity
- Collaboration
- Superior Performance
Quality & Safety
CSL Behring is committed to producing high-quality, safe and effective biotherapies to save lives and improve the quality of life for people with rare and serious medical conditions worldwide. Each step of the manufacturing process, from plasma donor to patient, reflects the company’s long-standing commitment to quality and safety.
Health, Safety & Environment (HS&E)
We employ dedicated Health, Safety & Environment (HS&E) teams at all our manufacturing sites. Our internal HSE Management System is consistent with the requirements of various globally recognized standards on Occupational Safety and Health, including AS/NZS 4801:2001, OHSAS 18001:2007, and ANSI Z10-2012, and goes beyond compliance to provide the flexibility to develop a sustainable safety culture within CSL Behring.
Learn more about CSL Behring at www.cslbehring.com
CSL focuses on the areas of Rare & Serious Diseases and Vaccines. Today, we compete on the global stage as one of the largest and fastest growing protein-based biotechnology businesses, and a leading provider of in-licensed vaccines.
CSL Behring is a global provider of plasma-derived & recombinant products. We have created one of the largest and most efficient plasma collection networks in the world and our team of over 1,100 R&D experts is dedicated to developing and delivering new therapies to solve unmet medical needs and save lives. Our products are used around the world to treat immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders.
Our Commitment
CSL Behring is passionate about safety, quality and the customers we serve. Our extensive research and development and range of support services demonstrate our ongoing commitment to those who count on our products. Our five core company values underscore our commitment to providing the best possible therapies and services:
- Patient Focus
- Innovation
- Integrity
- Collaboration
- Superior Performance
Quality & Safety
CSL Behring is committed to producing high-quality, safe and effective biotherapies to save lives and improve the quality of life for people with rare and serious medical conditions worldwide. Each step of the manufacturing process, from plasma donor to patient, reflects the company’s long-standing commitment to quality and safety.
Health, Safety & Environment (HS&E)
We employ dedicated Health, Safety & Environment (HS&E) teams at all our manufacturing sites. Our internal HSE Management System is consistent with the requirements of various globally recognized standards on Occupational Safety and Health, including AS/NZS 4801:2001, OHSAS 18001:2007, and ANSI Z10-2012, and goes beyond compliance to provide the flexibility to develop a sustainable safety culture within CSL Behring.
Learn more about CSL Behring at www.cslbehring.com